Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-14T19:45:06.142Z Has data issue: false hasContentIssue false

Synthetic cathinone (α-pyrrolidinohexanophenone): an emerging threat

Published online by Cambridge University Press:  01 September 2022

V. Rosello-Molina*
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
A. Hervas Aparisi
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
M. Simon Blanes
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
J. Tejera Nuñez
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
E. Moreno Soldado
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
I. Meri Abad
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
O. Sparano Ros
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
C. Ribera
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
M. Esteban
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
T. De Vicente Muñoz
Affiliation:
Hospital La Ribera, Psychiatry, Alzira, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Alpha-pyrrolidinohexanophenone (α-PHP) is a synthetic cathinone with uneven distribution throughout the world. Its use is not uniformly regulated and its distribution is legal in some European countries. Easily accessible and available through different websites. Synthetic cathinones inhibit monoamine transporters which include dopamine, norepinephrine, and serotonin, resulting in increased neurotransmitter synaptic concentration. Ways of administration show wide range regarding latency period. Onset and appearance of symptoms as well as their duration and intensity may fluctuate. A decreasing order of latency (oral, inhaled, sublingual and intravenous) has been reported. α-PHP can result in the appearance of psychiatric symptoms, include among others, intoxication with sensory perception disturbances and α-PHP -induced psychotic episodes.

Objectives

The aim of our study was to assess the epidemiology, clinical and legal features regarding Alpha-pyrrolidinohexanophenone (α-PHP).

Methods

Review the current bibliography to upgrade the existing knowledge. -Present assorted cases with diverse clinical features. All cases include variability through psychopathological interview, symptoms assessment and treatment response according to rating scales (PANSS, YMRS). -Evaluate different treatment administration ways during acute phase and after hospital discharge.

Results

Differences were observed after hospitalization in the response using diverse rating scales. We used antipsychotics to treat intoxication with sensory perception disturbances and α-PHP -induced psychotic episodes. α-PHP had a negative impact on the quality of life of the patients.

Conclusions

α-PHP is a synthetic cathinone with potential risk to mental health and life of users. It is mandatory to implement common legislation all through the European Union to prevent its use and possible implications on population’s mental health.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.